Biodesix Inc (BDSX) stock
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$9.88+0.09 (+0.92%)
Close on Nov 13, 2026Market cap $104.25MP/E –Yield –
Biodesix cash
Cash and short-term investments held at the end of each period.
Biodesix's cash was $28.41M at Sep 30, 2026. For fiscal 2025 it was $18.99M, down 27.9% from the year before. The highest annual figure on record is $62.31M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.99M | -27.9% |
| FY2024 | Dec 31, 2024 | $26.33M | -0.1% |
| FY2023 | Dec 31, 2023 | $26.37M | -38.9% |
| FY2022 | Dec 31, 2022 | $43.17M | +31.6% |
| FY2021 | Dec 31, 2021 | $32.80M | -47.4% |
| FY2020 | Dec 31, 2020 | $62.31M | +1039.5% |
| FY2019 | Dec 31, 2019 | $5.47M | -10.3% |
| FY2018 | Dec 31, 2018 | $6.09M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $28.41M | +70.2% |
| Q2 FY2026 | Jun 30, 2026 | $30.00M | +44.1% |
| Q1 FY2026 | Mar 31, 2026 | $25.57M | +44.6% |
| Q4 FY2025 | Dec 31, 2025 | $18.99M | -27.9% |
| Q3 FY2025 | Sep 30, 2025 | $16.69M | -47.0% |
| Q2 FY2025 | Jun 30, 2025 | $20.82M | -50.8% |
| Q1 FY2025 | Mar 31, 2025 | $17.69M | +52.8% |
| Q4 FY2024 | Dec 31, 2024 | $26.33M | -0.1% |
| Q3 FY2024 | Sep 30, 2024 | $31.49M | +58.0% |
| Q2 FY2024 | Jun 30, 2024 | $42.31M | +141.8% |
| Q1 FY2024 | Mar 31, 2024 | $11.58M | -54.3% |
| Q4 FY2023 | Dec 31, 2023 | $26.37M | -38.9% |
| Q3 FY2023 | Sep 30, 2023 | $19.93M | +30.6% |
| Q2 FY2023 | Jun 30, 2023 | $17.50M | -39.0% |
| Q1 FY2023 | Mar 31, 2023 | $25.36M | +53.6% |
| Q4 FY2022 | Dec 31, 2022 | $43.17M | +31.6% |
| Q3 FY2022 | Sep 30, 2022 | $15.26M | -68.2% |
| Q2 FY2022 | Jun 30, 2022 | $28.67M | -49.2% |
| Q1 FY2022 | Mar 31, 2022 | $16.51M | -70.2% |
| Q4 FY2021 | Dec 31, 2021 | $32.80M | -47.4% |
| Q3 FY2021 | Sep 30, 2021 | $48.00M | +635.1% |
| Q2 FY2021 | Jun 30, 2021 | $56.44M | +376.0% |
| Q1 FY2021 | Mar 31, 2021 | $55.42M | +696.3% |
| Q4 FY2020 | Dec 31, 2020 | $62.31M | +1039.5% |
| Q3 FY2020 | Sep 30, 2020 | $6.53M | -28.5% |
| Q2 FY2020 | Jun 30, 2020 | $11.86M | +94.6% |
| Q1 FY2020 | Mar 31, 2020 | $6.96M | – |
| Q4 FY2019 | Dec 31, 2019 | $5.47M | – |
| Q3 FY2019 | Sep 30, 2019 | $9.13M | – |
| Q4 FY2018 | Dec 31, 2018 | $6.09M | – |
See a number that looks wrong?